Comparing Enhertu vs Herceptin
| Enhertu (fam-trastuzumab deruxtecan) | Herceptin (trastuzumab) |
|
|---|
| Enhertu (fam-trastuzumab deruxtecan) | Herceptin (trastuzumab) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Breast Cancer - Metastatic, Solid Tumors, Non Small Cell Lung Cancer, Breast Cancer, Gastric Cancer. Enhertu may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer - Adjuvant, Esophageal Carcinoma, Breast Cancer, Gastric Cancer. Herceptin may also be used for purposes not listed in this medication guide. |
Related suggestions Breast Cancer
Gastric Cancer
Popular comparisons
|
|||||||
| More about Enhertu (fam-trastuzumab deruxtecan) | More about Herceptin (trastuzumab) | ||||||||
| Ratings & Reviews | |||||||||
|
Enhertu has an average rating of 8.1 out of 10 from a total of 35 ratings on Drugs.com. 74% of reviewers reported a positive effect, while 3% reported a negative effect. |
Herceptin has an average rating of 8.5 out of 10 from a total of 12 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Enhertu side effects |
View all Herceptin side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Enhertu prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
Other trastuzumab brands include: Hercessi, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
136.8 hours |
924 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 180 drugs are known to interact with Enhertu:
|
A total of 192 drugs are known to interact with Herceptin:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
September 25, 1998 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.